Stock To Buy In 2017 | The Best

Homebuilders like D.R. Horton (DHI) and PulteGroup (PHM) also thrived, both gaining over 80% due to strong economic conditions and low interest rates.

Outside of the S&P 500, small and mid-cap biotech companies saw even more explosive growth. Madrigal Pharmaceuticals led this category with a return in 2017. Madrigal Pharmaceuticals (MDGL): +516% Sangamo Therapeutics (SGMO): +438% Pieris Pharmaceuticals (PIRS): +437% Straight Path Communications (STRP): +436% Market Context and Sector Trends the best stock to buy in 2017

For investors seeking growth within major indices, NRG Energy was the top performer in the S&P 500 for 2017, yielding a total return of approximately . It was closely followed by Align Technology (the maker of Invisalign), which returned 131-143% depending on the specific measurement period. NRG Energy (NRG): +132% (Utilities) Align Technology (ALGN): +131% to +143% (Health Care) Vertex Pharmaceuticals (VRTX): +103% (Health Care) Wynn Resorts (WYNN): +95% (Consumer Discretionary) Boeing (BA): +89% (Industrials) Breakout Biotech & High-Growth Winners Homebuilders like D